Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatitis (NASH), liver inflammation, hepatocellular ballooning, liver fibrosis and steatosis

(S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatitis (NASH), liver inflammation, hepatocellular ballooning, liver fibrosis and steatosis

US Patent 12465582 · Granted Nov 11, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Functionalized N,N-dialkylamino phenyl ethers and their method of use2024
Aminothiazole compounds and methods using same2023
Aminothiazole compounds and methods using same2023
Compositions and methods for treatment of insulin resistance2023
Compositions and methods for treatment of insulin resistance2023
Compositions and methods for treatment of insulin resistance2023
Compositions and methods for treatment of insulin resistance2023
Functionalized N,N-dialkylamino phenyl ethers and their method of use2022
Bridged bicycloalkyl-substituted aminothiazoles and their methods of use2021
Beta lactams as modulators of glutamate uptake and methods for use thereof2020
Beta lactams as modulators of glutamate uptake and methods for use thereof2020
Compositions and methods for treatment of insulin resistance2020